|No||1||Date of announcement||2021/10/13||Time of announcement||17:22:30|
|Subject||A Malaysian patent on the Anti-CεMx (FB825) antibody was granted.|
|To which item it meets||paragraph 53||Date of events||2021/10/13|
1.Date of occurrence of the event:2021/10/13
2.Company name:ONENESS BIOTECH CO., LTD.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:FB825,anti-CεmX antibody, has been granted an Malaysian patent titled ”ANTI-CεMX ANTIBODIES CAPABLE OF BNDING TO HUMAN MIGE ON B LYMPHOCYTES” under the patent number MY-183134-A.
7.Any other matters that need to be specified:The assignee of the above-mentioned patent is Academia Sinica. Oneness Biotech owns the exclusive worldwide right of the patent for manufacture, use, and sale of the product.